· Event impact
State Street's XLV healthcare ETF outperforms Invesco's RSPH.
Transmission path
Differences in expense ratios, dividend yields, and weighting methodologies can lead to significant performance divergence between similar thematic ETFs, influencing investor allocation decisions.
Market mechanism
Differences in expense ratios, dividend yields, and weighting methodologies can lead to significant performance divergence between similar thematic ETFs, influencing investor allocation decisions.
Extended read
State Street's XLV healthcare ETF has demonstrated superior performance compared to Invesco's RSPH, driven by several key factors. XLV boasts a significantly lower expense ratio of 0.08% versus RSPH's 0.4%, and offers a higher dividend yield at 1.72% compared to RSPH's 0.7%. Over a five-year period, a $1,000 investment in XLV would have yielded $1,311, outperforming RSPH's $1,134. The performance disparity is also attributed to their differing weighting methodologies: XLV employs market-cap weighting, which favors large pharmaceutical companies, while RSPH uses an equal-weighting approach. This highlights how structural differences in ETF construction can lead to varied returns and influence investor preferences within the same sector.
Exposed assets
XLV · RSPH
Continuous event tracking, options routing, and portfolio overlap for this event and the assumptions it moves live inside Market Ontology. Start a trial →